Zazove Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-85,724
| Closed | -$1.19M | – | 177 |
|
|
2022
Q2 | $1.19M | Hold |
85,724
| – | – | 0.11% | 106 |
|
|
2022
Q1 | $1.67M | Buy |
+85,724
| New | +$1.67M | 0.15% | 94 |
|
|
2021
Q3 | $3.91M | Buy |
140,430
+88,195
| +169% | +$2.46M | 0.34% | 56 |
|
|
2021
Q2 | $1.55M | Hold |
52,235
| – | – | 0.14% | 91 |
|
|
2021
Q1 | $1.46M | Buy |
52,235
+45,907
| +725% | +$1.28M | 0.17% | 78 |
|
|
2020
Q4 | $179K | Buy |
+6,328
| New | +$179K | 0.02% | 106 |
|